Status:
COMPLETED
Assessing the Effectiveness of Midazolam Premedication
Lead Sponsor:
Pusan National University Hospital
Conditions:
Midazolam Premedication
Anxiety Preoperative
Eligibility:
FEMALE
20-65 years
Phase:
NA
Brief Summary
Pre-anesthetic dosing of midazolam is commonly used in many hospitals for the induction of anesthesia, but the effect is still controversial. The purpose of this study was to evaluate the effectivenes...
Detailed Description
Background * Midazolam premedication is a routine practice in many hospitals, but its efficacy remains controversial. We evaluated the effectiveness of midazolam premedication with respect to anxiety...
Eligibility Criteria
Inclusion
- American Society of Anesthesiologists physical status classification I or II
- Scheduled for elective thyroidectomy under general anesthesia
Exclusion
- Central nervous system disorders
- Major cardiovascular disease
- Chronic pain disorders
- Peripheral neuropathy
- Diabetes mellitus neuropathy
- Nephropathy
- Hepatopathy
- Taking any medication affecting the central nervous system or heart rate
- Alcohol or drug abuse
- Pregnancy
- Contraindication to midazolam premedication
Key Trial Info
Start Date :
July 19 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 15 2017
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT03325335
Start Date
July 19 2016
End Date
August 15 2017
Last Update
October 31 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pusan national university hospital
Busan, South Korea